These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3091432)

  • 1. Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human use.
    Beuvery EC; Speijers GJ; Lutz BI; Freudenthal D; Kanhai V; Haagmans B; Derks HJ
    Dev Biol Stand; 1986; 63():117-28. PubMed ID: 3091432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrier protein.
    Beuvery EC; Roy R; Kanhai V; Jennings HJ
    Dev Biol Stand; 1986; 65():197-204. PubMed ID: 3104115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.
    Beuvery EC; Miedema F; van Delft R; Haverkamp J
    Infect Immun; 1983 Apr; 40(1):39-45. PubMed ID: 6187693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods.
    Beuvery EC; vd Kaaden A; Kanhai V; Leussink AB
    Vaccine; 1983 Dec; 1(1):31-6. PubMed ID: 6442499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
    Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice.
    Beuvery EC; van Delft RW; Miedema F; Kanhai V; Nagel J
    Infect Immun; 1983 Aug; 41(2):609-17. PubMed ID: 6409811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J; Deane S; Ashton L; Borrow R; Goldblatt D; Andrews N; Balmer P; Morris R; Kroll JS; Miller E
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1100-4. PubMed ID: 15539513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine potential of meningococcal group C polysaccharide-tetanus toxoid conjugate.
    Beuvery EC; Miedema F; van Delft RW; Haverkamp J; Tiesjema RH; Nagel J
    J Infect; 1983 May; 6(3):247-55. PubMed ID: 6411824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide.
    van de Wiel PA; Witvliet MH; Evenberg D; Derks HJ; Beuvery EC
    Vaccine; 1987 Mar; 5(1):33-8. PubMed ID: 2437718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D
    Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.
    Bruge J; Bouveret-Le Cam N; Danve B; Rougon G; Schulz D
    Vaccine; 2004 Mar; 22(9-10):1087-96. PubMed ID: 15003635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
    Devi SJ; Zollinger WD; Snoy PJ; Tai JY; Costantini P; Norelli F; Rappuoli R; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1045-52. PubMed ID: 9038314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate.
    Coquillat D; Bruge J; Danve B; Latour M; Hurpin C; Schulz D; Durbec P; Rougon G
    Infect Immun; 2001 Nov; 69(11):7130-9. PubMed ID: 11598089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
    Bartoloni A; Norelli F; Ceccarini C; Rappuoli R; Costantino P
    Vaccine; 1995 Apr; 13(5):463-70. PubMed ID: 7543714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity.
    Lockyer K; Gao F; Francis RJ; Eastwood D; Khatri B; Stebbings R; Derrick JP; Bolgiano B
    Vaccine; 2020 Mar; 38(13):2859-2869. PubMed ID: 32089463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
    Lee CH; Kuo WC; Beri S; Kapre S; Joshi JS; Bouveret N; LaForce FM; Frasch CE
    Vaccine; 2009 Jan; 27(5):726-32. PubMed ID: 19063929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.